Advertisement
Table 5 WA and STD Productivity Loss and Indirect Costs in Propensity Score Matched Cohorts with WA and STD Eligibility
| Measure | Patients with WA and STD Eligibility | ||||
|---|---|---|---|---|---|
| With CVERP | Without CVERP | p-value | |||
| N = 3,362 | N = 3,362 | ||||
| n/mean | %/SD | n/mean | %/SD | ||
| During the 1st month of follow-up: | |||||
| Patients reporting WA/STD (n, %) | 2,980 | 88.6 | 2,591 | 77.1 | <.001 |
| Monthly hours lost due to WA/STD (mean, SD) | 78.7 | 63.5 | 22.4 | 30.3 | <.001 |
| Indirect costs associated with WA/STD (mean, SD) | $1,744 | $1,293 | $624 | $785 | <.001 |
| Patients with ≥ 1 year of follow-up (n, %) | 2,030 | 60.4 | 2,249 | 66.9 | |
| During the 1st year of follow-up: | |||||
| Patients reporting WA/STD (n, %) | 1,917 | 94.4 | 2,093 | 93.1 | 0.07 |
| Monthly hours lost due to WA/STD (mean, SD) | 35.0 | 29.3 | 21.4 | 14.1 | <.001 |
| Indirect costs associated with WA/STD (mean, SD) | $847 | $572 | $610 | $374 | <.001 |
| Patients with ≥ 2 years of follow-up (n, %) | 1,184 | 35.2 | 1,364 | 40.6 | |
| During the 2nd year of follow-up: | |||||
| Patients reporting WA/STD (n, %) | 1,088 | 91.9 | 1,294 | 94.9 | 0.002 |
| Monthly hours lost due to WA/STD (mean, SD) | 22.2 | 18.0 | 21.2 | 13.7 | 0.12 |
| Indirect costs associated with WA/STD (mean, SD) | $590 | $389 | $590 | $337 | 0.99 |
| Patients with ≥ 3 years of follow-up (n, %) | 622 | 18.5 | 759 | 22.6 | |
| During the 3rd year of follow-up: | |||||
| Patients reporting WA/STD (n, %) | 581 | 93.4 | 723 | 95.3 | 0.14 |
| Monthly hours lost due to WA/STD (mean, SD) | 21.3 | 16.2 | 20.7 | 12.9 | 0.44 |
| Indirect costs associated with WA/STD (mean, SD) | $561 | $359 | $568 | $305 | 0.68 |
